A Caltech Library Service

RECQL4, mutated in the Rothmund–Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway

Yin, Jinhu and Kwon, Yong Tae and Varshavsky, Alexander and Wang, Weidong (2004) RECQL4, mutated in the Rothmund–Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. Human Molecular Genetics, 13 (20). pp. 2421-2430. ISSN 0964-6906. doi:10.1093/hmg/ddh269.

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item:


The Rothmund–Thomson syndrome (growth retardation, skin and bone defects, predisposition to cancer) and the RAPADILINO syndrome are caused by mutations in the RECQL4 gene. The 133 kDa RECQL4 is a putative DNA helicase, a member of the family that includes the BLM and WRN helicases. The latter are mutated, respectively, in the Bloom and Werner syndromes, whose manifestations include predisposition to cancer. Using antibodies to human RECQL4, we found that the bulk of RECQL4 was present in a cytoplasmic extract of HeLa cells, in contrast to the largely nuclear BLM and WRN helicases. However, in untransformed WI-38 fibroblasts, RECQL4 was found to be largely nuclear, and was present at significantly lower total levels than in transformed HeLa cells. RECQL4 from HeLa cells was isolated as a stable complex with UBR1 and UBR2. These 200 kDa proteins are ubiquitin ligases of the N-end rule pathway, whose substrates include proteins with destabilizing N-terminal residues. The functions of this proteolytic pathway include the regulation of peptide import, chromosome stability, meiosis, apoptosis and cardiovascular development. Although the known role of UBR1 and UBR2 is to mediate polyubiquitylation (and subsequent degradation) of their substrates, the UBR1/2-bound RECQL4 was not ubiquitylated in vivo, and was a long-lived protein in HeLa cells. The isolated RECQL4–UBR1/2 complex had a DNA-stimulated ATPase activity, but was inactive in DNA-based assays for helicases and translocases, the assays in which the BLM helicase was active. We discuss ramifications of these results, possible functions of RECQL4, and the involvement of the N-end rule pathway.

Item Type:Article
Related URLs:
URLURL TypeDescription DOIArticle
Varshavsky, Alexander0000-0002-4011-258X
Additional Information:© 2004 Oxford University Press. Received May 6, 2004; Revised and Accepted August 11, 2004. First published online: August 18, 2004. We thank Jee Young An for carrying out DNA transfection tests with AG05013 cells, and the National Cell Culture Center for providing HeLa cells. This work was supported, in part, by the grants to W.W. from the Ellison Medical Foundation, the Rett Syndrome Research Foundation, and the Fanconi Anemia Research Foundation, by the NIH Grant GM31530 and the Max Planck Research Award (Germany) to A.V. and by the NIH Grant GM69482 to Y.T.K.
Funding AgencyGrant Number
Ellison Medical FoundationUNSPECIFIED
Rett Syndrome Research FoundationUNSPECIFIED
Fanconi Anemia Research FoundationUNSPECIFIED
Max Planck SocietyUNSPECIFIED
Issue or Number:20
Record Number:CaltechAUTHORS:20111004-142209812
Persistent URL:
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:25852
Deposited By: Tony Diaz
Deposited On:05 Oct 2011 16:54
Last Modified:09 Nov 2021 16:36

Repository Staff Only: item control page